Cargando…
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy
SIMPLE SUMMARY: Esophageal squamous cell carcinoma (ESCC) represents roughly 85–90% of all esophageal carcinoma patients in China. Immunotherapy is used to treat an increasing number of ESCC patients in clinical practice. This study aims to understand the molecular heterogeneity and the tumor immune...
Autores principales: | Zheng, Yulong, Gao, Qiqi, Su, Xingyun, Xiao, Cheng, Yu, Bo, Huang, Shenglin, Sun, Yifeng, Wu, Sheng, Wo, Yixin, Xu, Qinghua, Xu, Nong, Yu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599230/ https://www.ncbi.nlm.nih.gov/pubmed/36291754 http://dx.doi.org/10.3390/cancers14204970 |
Ejemplares similares
-
Immunotherapy in Squamous Cell Cancer of the Esophagus
por: Thuss-Patience, Peter, et al.
Publicado: (2022) -
DNA methylation markers for disease progression and survival in Barrett’s Esophagus
por: Taenzer, Marc, et al.
Publicado: (2013) -
90-gene signature assay for tissue origin diagnosis of brain metastases
por: Zheng, Yulong, et al.
Publicado: (2019) -
Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus
por: Xu, Yingying, et al.
Publicado: (2021) -
Trimodal therapy in squamous cell carcinoma of the esophagus
por: Matuschek, C, et al.
Publicado: (2011)